Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Clinical trial NCT05624450 · RECRUITING

Trial details

NCT number: NCT05624450
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Viral Lung Infection and Acute Respiratory Failure

Start date: 2022-12-13
Primary completion: 2027-11-04
Enrollment: 3527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.